Premier Pharmacy Services (Good Health Inc.), Baldwin Park, CA

Is Premier Pharmacy Services (Good Health Inc.) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Premier Pharmacy Services (Good Health Inc.) hold a California pharmacy license?

No license with this exact name and city was found in the California State Board of Pharmacy file dated Nov 6, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file lists current licenses only, not revoked, surrendered or cancelled ones. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054018852 for GOOD HEALTH INC, BALDWIN PARK, CA, status CHANGE OF OWNERSHIP, as of Nov 13, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0001565 for Good Health, Inc., BALDWIN PARK, CA, status Expired, as of Nov 10, 2026.

Has Premier Pharmacy Services (Good Health Inc.) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Dec 6, 2019) and 1 FMD-145 letter (Dec 6, 2019) for Premier Pharmacy Services (Good Health Inc.). State board actions: record found. The California State Board of Pharmacy’s posted disciplinary decisions on facility licenses lists “Through a disciplinary action of the Board, the license is voluntarily surrendered. The effective date shall be stayed until April 15, 2023, at which time the pharmacy shall be sold or closed” dated Nov 16, 2022, case AC 6863 on license PHY 53274. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Good Health Inc.; Premier Pharmacy Services
Location
Baldwin Park, CA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
0
Latest action on that page
Dec 6, 2019
FDA Data Dashboard inspections
1 inspection: 1 VAI; 1 published Form 483
Form 483 text on this page
1 Form 483, 2 observations
State board records
No exact match

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Good Health Inc., (dba Premier Pharmacy Services), a 503A facility, with 2 dated actions.

Document
Dec 6, 2019FMD-145 letterFMD-145 Letter Issued 12/06/2019Not linked by FDA
Dec 6, 2019State referral letterState Referral Letter Issued 12/06/2019Not linked by FDA

An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Good Health, Inc., Baldwin Park, CA (FEI number 3014549940), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Nov 29, 2018Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)30145499401073741

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Nov 8, 2018 to Nov 29, 2018: 2 observations

Firm on the cover
Good Health, Inc. DBA Premier Pharmacy Services, 410 Cloverlea f Dr, Baldwin Park, CA 91706-6511
FEI number
3014549940
Establishment type on the cover
Producer of Sterile Drug Products
FDA district office on the cover
19701 Fairchild Irvine, CA 92612-2445
Matched to this page by
FEI number on the cover; linked from Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

You produced beta-lactam drugs without providing adequate cleaning of work surfaces to prevent cross-contamination.

Specifically,

Drug products containing penicillin are produced in the same ISO Class 5 environment as non-penicillin beta-lactam drug_products; only a cleaning utilizing Sterile <Redacted B4> is performed between batches. <Redacted B>There are <Redacted B4> Class 5 hoods within the ISO Class 7 buffer room used by the firm to produce sterile drugs. There is no assurance that the cleaning process used within the hoods prevents cross~contamination between penicillin and non-penicillin beta-lactam drug products.

For example, on 11/09/18, I observed the production the following drug products in Hood# E28777: Ertapenem S00mg/1 00mL NS, Rx# <Redacted B4> followed by Vancomycin HCI 850mg, Rx# <Redacted B4> followed by Penicillin G Potassium, 3MU/D5W S0mL, Rx# <Redacted B4> . Between the production of these drug products, only a cleaning utilizing <Redacted B4> is performed. There is no cleaning agent used between products to effectively breakdown penicillin activity or the beta-lactam ring.

Observation 2

You did not make adequate product evaluation and take remedial action where actionable microbial contamination was found to be present in the ISO 5 classified aseptic processing area during aseptic production.

Specifically,

Actionable microbial contamination was discovered inside the ISO Class S aseptic processing environment; however no evaluation of product impact was made.

For example, on 11/30/2016, an environmental monitoring sample collected from ISO Class 5 work surface, Hood# 67437, during cleanroom certification resulted in an actionable excursion of <Redactted B4> colony forming units. There were no documented corrective actions performed. In addition, there were no evaluations conducted for products made on or before 11/30/16 to include: Cefepime lgm/50rnL NS, Rx# <Redacted B4> Rx# <Redacted B4> Vanco 1 grn/250mL, Rx#~ <Redacted B4>

State board of pharmacy records

No license with this exact name and city was found in the California State Board of Pharmacy file dated Nov 6, 2026. A pharmacy can hold its license under a different legal name, so this is not a finding that it is unlicensed. The file lists current licenses only, not revoked, surrendered or cancelled ones. Board file.

Board actions

As the board words them, newest first. An entry that is a complaint, charge or notice the board filed is a charge, not a final decision; only an order or final action records the outcome.

What this covers: Facility license decisions from the board’s quarterly Disciplinary Actions pages (87 of 88 quarters had a facility section). These are final decisions; accusations filed and immediate protection orders are not included. Actions in the data are dated Jan 5, 2005 to Oct 28, 2026.

Nonresident licenses in other states

These boards list a nonresident license whose record names this pharmacy’s own name, city and state.

Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).

LicenseType as the board gives itName on the board recordLocationStatus
054018852LICENSED PHARMACYGOOD HEALTH INCBALDWIN PARK, CACHANGE OF OWNERSHIP

Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).

LicenseType as the board gives itName on the board recordLocationStatus
A9-0001565Non Resident PharmacyGood Health, Inc.BALDWIN PARK, CAExpired

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.